Diyabet Yönetiminde Rejeneratif tıp yaklaşımları
Tip 1 ve Tip 2 diyabette kan şekeri kontrolünü desteklemek, insülin duyarlılığını artırmak ve diyabetik komplikasyonları azaltmak için rejeneratif yaklaşımlar.
Diabetes and Regenerative Medicine
Diabetes mellitus affects over 500 million people worldwide and is characterized by impaired blood sugar regulation. In Type 1 diabetes, the immune system destroys insulin-producing beta cells. In Type 2 diabetes, the body develops resistance to insulin and beta cells gradually lose function.
Traditional diabetes management focuses on blood sugar control through medications, insulin therapy, and lifestyle modifications. While essential, these approaches do not address the underlying damage to beta cells or restore normal pancreatic function.
Regenerative medicine approach offers a promising approach to diabetes management by potentially supporting beta cell regeneration, improving insulin sensitivity, and addressing the inflammatory processes that contribute to disease progression.
blogPages.diabetesManagement.conditionsTitle
blogPages.diabetesManagement.conditionsDescription
blogPages.diabetesManagement.benefitsTitle
blogPages.diabetesManagement.benefitsDescription
blogPages.diabetesManagement.researchTitle
blogPages.diabetesManagement.researchDescription
blogPages.diabetesManagement.processTitle
blogPages.diabetesManagement.processDescription
Metabolic Assessment
Comprehensive blood tests including HbA1c, C-peptide, insulin levels, and pancreatic function evaluation.
Personalized Protocol
Development of a customized care plan based on your diabetes type and metabolic profile.
Stem Cell Administration
Treatment delivered through intravenous infusion or targeted delivery methods as appropriate.
Metabolic Monitoring
Regular follow-up with blood sugar tracking and metabolic parameter assessment to measure progress.
Frequently Asked Questions
Watch Our Patient Stories & Expert Insights
See real results and hear from our medical team about stem cell therapy treatments, procedures, and patient outcomes.
Uluslararası Hasta Koordinasyonu
StemCell Longevita, uluslararası bir hasta koordinasyon platformu olarak faaliyet göstermektedir. Hastaları, hekim değerlendirmesi ve geçerli düzenleyici çerçeveler dahilinde rejeneratif tıp uygulamaları sunan lisanslı tıbbi kurumlarla buluşturuyoruz. Tüm tıbbi kararlar ve prosedürler yalnızca yetkili sağlık profesyonelleri tarafından gerçekleştirilir. StemCell Longevita doğrudan tıbbi tedavi sağlamamaktadır.
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as medical advice. Stem cell therapy is an evolving field, and outcomes may vary by individual. The treatments described on this site have not been fully evaluated or approved by the FDA or equivalent regulatory bodies in all jurisdictions.
The FDA has not approved stem cell applications for most conditions listed on this website. Results mentioned are based on clinical observations, published research, and patient-reported outcomes. Individual results may vary and no specific outcomes are assured for any individual patient.
Bu web sitesindeki bilimsel yayınların yer alması, düzenleyici onay veya garantili klinik sonuçlar anlamına gelmez. Belirli uygulamalar, endikasyon ve yargı yetkisine bağlı olarak araştırma aşamasında kabul edilebilir.
Always consult with a qualified healthcare professional before making any medical decisions. Do not disregard professional medical advice or delay seeking treatment based on information found on this website.